pembrolizumab
merck
['tnbc']
last day of #asco22. #sitc caught dr. lajos pusztai of presenting data from the keynote-522 trial investigating the #immunotherapy + chemotherapy combination for early treatment of #tnbc. see you at #sitc22 in nov. #immune2cancer #cim22 
Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.